Contribution of measurable residual disease status to prediction accuracy of relapse and survival in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation.

Eduardo Rodríguez-Arbolí Megan Othus Corentin Orvain Lucas C Zarling Brenda M Sandmaier Filippo Milano Gary Schoch Chris Davis H Joachim Deeg Frederick R Appelbaum Rainer Storb Roland B Walter

Haematologica

Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA; Department of Epidemiology, University of Washington, Seattle, WA.

Published: January 2023

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827162	PMC
http://dx.doi.org/10.3324/haematol.2022.281631	DOI Listing

Publication Analysis

Top Keywords

contribution measurable

measurable residual

residual disease

disease status

status prediction

prediction accuracy

accuracy relapse

relapse survival

survival adults

adults acute

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!